Restrictive chronic lung allograft dysfunction: Where are we now?
about
The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationIntegrated analysis of transcription factor, microRNA and LncRNA in an animal model of obliterative bronchiolitisAutologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.Role of gastroesophageal reflux disease in lung transplantation."White-Out" After Lung Transplantation: A Multicenter Cohort Description of Late Acute Graft Failure.The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.Chronic lung allograft dysfunction phenotypes and treatment.Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.Restrictive allograft syndrome after lung transplantation: new radiological insights.Phenotypes of Chronic Lung Allograft Dysfunction: Getting Closer Step by Step?The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients
P2860
Q28085440-CB444A24-C1DF-4F7C-BC44-45412668BFA3Q35919272-4766263F-0B87-4F19-B709-F3B806874F8EQ37528715-4DC0634D-674B-43C8-964F-3B82CCBCF374Q38645350-F8766934-8618-44DB-A580-48822C3349C4Q38784394-84AD6FFB-08DF-422A-9ED8-A0A30704C911Q39179919-7DBAE89A-BBEC-45CA-8836-83FE16F8E740Q39299749-8B364964-30B5-4B01-963F-2DB50DAD6594Q40255111-4B0A3569-CAD1-4A65-B1B5-0591D6E4D260Q40998457-D4DC3531-FDDE-428F-9B2E-997EBF5AA381Q41303108-669D517C-6F7F-4FBB-9F13-EA5B4E7F6AB7Q47153176-BB6ADD97-433D-4FB4-BE2E-925624DDFE91Q48204227-A896C7A3-4E91-4CB2-AA98-5FB4470ED9A4Q48273916-48313EF2-E245-4F59-9E3B-E516832E3011Q50071570-03EEEEDA-90AF-430A-B32C-F7DFAC85BB99Q58736851-1608FB75-F9B1-4E19-86EB-EC1FC14E8316
P2860
Restrictive chronic lung allograft dysfunction: Where are we now?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Restrictive chronic lung allograft dysfunction: Where are we now?
@en
Restrictive chronic lung allograft dysfunction: Where are we now?
@nl
type
label
Restrictive chronic lung allograft dysfunction: Where are we now?
@en
Restrictive chronic lung allograft dysfunction: Where are we now?
@nl
prefLabel
Restrictive chronic lung allograft dysfunction: Where are we now?
@en
Restrictive chronic lung allograft dysfunction: Where are we now?
@nl
P2093
P1476
Restrictive chronic lung allograft dysfunction: Where are we now?
@en
P2093
David Ruttens
Elly Vandermeulen
Geert Verleden
Hannelore Bellon
Lieven J Dupont
Stijn E Verleden
P304
P356
10.1016/J.HEALUN.2014.11.007
P577
2014-11-11T00:00:00Z